Interest Expense On Debt Cambiamento Data
AbbVie USD 555M 3M 2023-09
ALKERMES USD 6.01M 322K 2023-09
Alnylam Pharmaceuticals USD 31.34M 445K 2023-12
Amgen USD 821M 62M 2023-12
Biogen USD 71.5M 7.7M 2023-12
BioMarin Pharmaceutical USD 6.1M 2.32M 2023-12
Cytokinetics USD 7.16M 28K 2023-12
Dynavax Technologies USD 1.69M 1000 2023-12
Enanta Pharmaceuticals USD 3.15M 1.15M 2023-09
Gilead Sciences USD 252M 20M 2023-12
Halozyme Therapeutics USD 5.22M 715K 2023-12
Incyte USD 804K 181K 2023-12
Ionis Pharmaceuticals USD 4.56M 355K 2023-12
Nektar Therapeutics USD 5.91M 242K 2023-09
Neurocrine Biosciences USD 1.1M 200K 2023-09
Pfizer USD 689M 6M 2023-12
Regeneron Pharmaceuticals USD 18.3M 500K 2023-12
Repligen USD 7.84M 7.11M 2023-12
Rigel Pharmaceuticals USD 1.9M 37K 2023-09
Sarepta Therapeutics USD 5.23M 5K 2023-09
Teva Pharmaceutical Industries USD 247M 31M 2023-09
Vertex Pharmaceuticals USD 10.9M 300K 2023-09
Xoma USD 0 0 2022-06



Neurocrine Biosciences Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.